Ordinary Adjustment | Solactive Global Health Services & Technology EMEA | Effective Date 16th October 2025
Solactive Global Health Services & Technology EMEA:
In the ordinary adjustment, the following composition will be implemented effective open 16th October 2025:
ALCON INC |
ALK-ABELLO A/S |
ASTRAZENECA PLC |
BIOMERIEUX |
COLOPLAST AS CLASS B |
DEMANT A/S |
DIASORIN SPA |
DR SULAIMAN AL HABIB MEDICAL SERVICES GROUP CO |
ESSILORLUXOTTICA |
FRESENIUS MEDICAL CARE AG & CO KGAA |
FRESENIUS SE & CO KGAA |
GSK PLC |
HALEON PLC |
HIKMA PHARMACEUTICALS PLC |
INTERNATIONAL HOLDINGS CO PJSC |
IPSEN SA |
KONINKLIJKE PHILIPS NV |
LABORATORIOS FARMACEUTICOS R |
LONZA GROUP AG |
MERCK KGAA |
MLP SAGLIK HIZMETLERI AS |
MOUWASAT MEDICAL |
NOVARTIS AG |
ORION OYJ CLASS B |
RECORDATI SPA |
RICHTER GEDEON VEGYESZETI GYAR NYILVANOSAN MUKODO RT |
ROCHE HOLDING AG |
SANDOZ GROUP AG |
SANOFI SA |
SIEGFRIED HOLDING AG-REG |
SIEMENS HEALTHINEERS AG |
SONOVA HOLDING AG |
SPECIALIZED MEDICAL ORD |
STRAUMANN HOLDING AG |
SWEDISH ORPHAN BIOVITRUM AB |